ZA200407149B - Triglyceride fat. - Google Patents

Triglyceride fat. Download PDF

Info

Publication number
ZA200407149B
ZA200407149B ZA200407149A ZA200407149A ZA200407149B ZA 200407149 B ZA200407149 B ZA 200407149B ZA 200407149 A ZA200407149 A ZA 200407149A ZA 200407149 A ZA200407149 A ZA 200407149A ZA 200407149 B ZA200407149 B ZA 200407149B
Authority
ZA
South Africa
Prior art keywords
fat
triglycerides
acid residues
fatty acid
phase
Prior art date
Application number
ZA200407149A
Other languages
English (en)
Inventor
Eckhard Floeter
Original Assignee
Unilever Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Plc filed Critical Unilever Plc
Publication of ZA200407149B publication Critical patent/ZA200407149B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/001Spread compositions
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00Other edible oils or fats, e.g. shortenings, cooking oils
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/555Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
    • A61K47/557Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells the modifying agent being biotin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/66Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells
    • A61K47/665Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells the pre-targeting system, clearing therapy or rescue therapy involving biotin-(strept) avidin systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6891Pre-targeting systems involving an antibody for targeting specific cells
    • A61K47/6897Pre-targeting systems with two or three steps using antibody conjugates; Ligand-antiligand therapies
    • A61K47/6898Pre-targeting systems with two or three steps using antibody conjugates; Ligand-antiligand therapies using avidin- or biotin-conjugated antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11CFATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • C11C3/04Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
    • C11C3/10Ester interchange
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C12N15/877Techniques for producing new mammalian cloned embryos
    • C12N15/8775Murine embryos
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0006Modification of the membrane of cells, e.g. cell decoration
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0603Embryonic cells ; Embryoid bodies
    • C12N5/0604Whole embryos; Culture medium therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • Polymers & Plastics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
ZA200407149A 2002-04-09 2004-09-07 Triglyceride fat. ZA200407149B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02076376 2002-04-09

Publications (1)

Publication Number Publication Date
ZA200407149B true ZA200407149B (en) 2006-02-22

Family

ID=28685931

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200407149A ZA200407149B (en) 2002-04-09 2004-09-07 Triglyceride fat.

Country Status (12)

Country Link
US (1) US7524524B2 (es)
EP (1) EP1492410B1 (es)
AT (1) ATE457649T1 (es)
AU (1) AU2003218752B2 (es)
BR (1) BR0308747B1 (es)
CA (1) CA2481700C (es)
DE (1) DE60331298D1 (es)
MX (1) MXPA04009732A (es)
PL (1) PL205287B1 (es)
RU (1) RU2307517C2 (es)
WO (1) WO2003084337A1 (es)
ZA (1) ZA200407149B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6388113B1 (en) 1999-06-04 2002-05-14 Consejo Superior De Investigaciones Cientificas ( Csic) High oleic/high stearic sunflower oils
BRPI0313344B1 (pt) * 2002-08-12 2015-05-26 Unilever Nv Preparação de uma fase graxa, emulsão água-em-óleo comestível, seu processo de preparação, composição comestível e seus processos de preparação
AU2004262853B2 (en) 2003-07-17 2008-06-05 Upfield Europe B.V. Process for the preparation of an edible dispersion comprising oil and structuring agent
GB0409156D0 (en) * 2004-04-24 2004-05-26 Haye Pierre A procedure to manufacture a texturized, thermo-resistant and thermo-irreversible gel composed of vegetable and/or animal fats and the product made with this
BRPI0606151A8 (pt) * 2005-01-28 2017-09-19 Unilever Nv Dispersão entornável comestível e processo para a preparação de uma dispersão comestível contendo gordura
WO2006087092A2 (en) 2005-02-17 2006-08-24 Unilever N.V. Fat granules
EP1931211B1 (en) * 2005-09-26 2008-12-10 Unilever N.V. Non-hydrogenated hardstock fat
US8431177B2 (en) * 2007-08-02 2013-04-30 Bunge Oils, Inc. Shortenings and methods of making and using thereof
ATE553655T1 (de) * 2008-01-10 2012-05-15 Team Foods Colombia Sa Festes, trans-fettsäurefreies fettprodukt mit niedrigem gehalt an gesättigten fetten
WO2009152150A1 (en) * 2008-06-11 2009-12-17 General Mills Marketing, Inc. Hydrated fat piece compositions and dough articles made therefrom
EA201100983A1 (ru) 2008-12-19 2011-12-30 Юнилевер Н.В. Съедобные жировые порошки
WO2010069750A1 (en) * 2008-12-19 2010-06-24 Unilever Nv Edible fat powders
EP2584907B1 (en) 2010-06-22 2014-04-23 Unilever NV Edible fat powders
CA2820360C (en) 2010-12-17 2018-10-30 Unilever Plc Edible water in oil emulsion
EP2651234B1 (en) 2010-12-17 2015-01-21 Unilever N.V. Process of compacting a microporous fat powder and compacted fat powder so obtained
EP2706863B1 (en) 2011-05-09 2017-10-04 General Mills, Inc. Fat compositions including shortening particles and shortening compositions without added non-interesterified hardstock fat, and related products
JP5173086B2 (ja) * 2011-05-17 2013-03-27 日清オイリオグループ株式会社 ノーテンパー型ハードバターとして使用可能な油脂組成物
EP2840899B1 (en) 2012-04-27 2016-09-14 General Mills, Inc. Fat particle compositions containing salt, dough and baked dough articles made therefrom, and related methods
EP2692238A1 (en) * 2012-08-03 2014-02-05 Bunge Növényolajipari Zártköruen Muködo Részvénytársasag New fat blend composition
BR112017019892B1 (pt) 2015-03-18 2022-03-22 Cargill, Incorporated Emulsão de água em óleo com baixo teor de gordura, produto alimentício e composição
CN111378534B (zh) * 2018-12-27 2022-11-25 丰益(上海)生物技术研发中心有限公司 结构酯组合物及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1107206A (en) 1964-12-28 1968-03-27 Nat Biscuit Co Hard butter and chocolate coating composition containing same
EP0089082B1 (en) 1982-03-12 1985-07-24 Unilever N.V. Margarine fat blend, and a process for producing said fat blend
GB8432058D0 (en) * 1984-12-19 1985-01-30 Unilever Plc Edible fat
DE69103845T2 (de) * 1990-08-02 1995-02-02 Unilever Nv Verbesserung essbarer Fette.
DK0530864T3 (da) * 1991-07-03 1995-08-28 Unilever Plc Forbedrede chokoladesammensætninger
US5470598A (en) * 1994-03-23 1995-11-28 The Procter & Gamble Company Beta-prime stable low-saturate, low trans, all purpose shortening
US6238926B1 (en) * 1997-09-17 2001-05-29 Cargilll, Incorporated Partial interesterification of triacylglycerols
GB2350618A (en) 1999-06-01 2000-12-06 Danisco Shortening systems comprising a non-hydrogenated vegetable oil and either a stearine fraction or a saturated fatty acid diglyceride

Also Published As

Publication number Publication date
BR0308747A (pt) 2005-01-11
RU2307517C2 (ru) 2007-10-10
AU2003218752A1 (en) 2003-10-20
WO2003084337A1 (en) 2003-10-16
US7524524B2 (en) 2009-04-28
AU2003218752B2 (en) 2006-12-07
CA2481700A1 (en) 2003-10-16
RU2004132825A (ru) 2005-06-10
ATE457649T1 (de) 2010-03-15
PL371725A1 (en) 2005-06-27
EP1492410B1 (en) 2010-02-17
MXPA04009732A (es) 2005-01-11
PL205287B1 (pl) 2010-03-31
EP1492410A1 (en) 2005-01-05
DE60331298D1 (de) 2010-04-01
BR0308747B1 (pt) 2013-12-17
CA2481700C (en) 2012-10-09
US20050220965A1 (en) 2005-10-06

Similar Documents

Publication Publication Date Title
ZA200407149B (en) Triglyceride fat.
AU2002220655B2 (en) Edible spread containing a natural fat phase
CA2486634C (en) Triglyceride fat
AU2002220655A1 (en) Edible spread containing a natural fat phase
AU2002219057A1 (en) Edible spread containing a natural fat phase
HU225065B1 (en) Natural triglyceride fat and its use
PL180616B1 (pl) Sposób wytwarzania mieszanego tluszczu stosowanego do margaryn i srodków typu W/O do smarowania pieczywa PL PL PL PL PL PL PL
ZA200500479B (en) Triglyceride fat
WO2007022897A1 (en) Non-hydrogenated hardstock fat
JPH09501465A (ja) 健康によいスプレッド脂肪
AU2003248335B2 (en) Triglyceride fat suitable for spread manufacture
ZA200306441B (en) Edible spread containing a natural fat phase.